EFFECTS OF DAILY KEFIR CONSUMPTION DURING MEDICAL NUTRITION THERAPY ON BODY COMPOSITION AND PSYCHOLOGICAL WELL-BEING IN WOMEN WITH OBESITY
1 other identifier
interventional
68
1 country
1
Brief Summary
This randomized controlled study evaluated the effects of daily kefir consumption as an adjunct to medical nutrition therapy on body composition, biochemical parameters, gastrointestinal symptoms, bowel habits, and psychological well-being in women with obesity. Participants were randomly assigned to receive either 200 mL of plain kefir daily together with individualized medical nutrition therapy or individualized medical nutrition therapy alone for 12 weeks. Assessments were performed at baseline, week 6, and week 12. The primary outcome was change in body weight. Secondary outcomes included changes in body composition, biochemical parameters, gastrointestinal symptoms, bowel habits, and psychological well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFirst Submitted
Initial submission to the registry
September 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedSeptember 25, 2026
August 1, 2026
4 months
September 18, 2026
September 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in body weight (kg) from baseline to week 12
Body weight was measured in kilograms using a calibrated digital scale. The primary outcome was the change in body weight from baseline to week 12.
Baseline and week 12
Secondary Outcomes (13)
Change in body mass index (kg/m²)
Baseline and week 12
Change in body fat percentage
Baseline and week 12
Change in fat mass (kg)
Baseline and week 12
Change in muscle mass (kg)
Baseline and week 12
Change in visceral fat level
Baseline and week 12
- +8 more secondary outcomes
Study Arms (2)
Medical Nutrition Therapy + Kefir
EXPERIMENTALParticipants received individualized medical nutrition therapy together with 200 mL/day of plain kefir for 12 weeks.
Medical Nutrition Therapy
ACTIVE COMPARATORParticipants received individualized medical nutrition therapy alone for 12 weeks.
Interventions
Participants consumed 200 mL of plain kefir daily for 12 weeks in addition to individualized medical nutrition therapy.
Participants received individualized medical nutrition therapy delivered by a registered dietitian throughout the 12-week intervention period.
Eligibility Criteria
You may qualify if:
- Female participants aged 18 years or older. Diagnosis of obesity (BMI ≥30 kg/m²). Willingness to participate in the study and comply with the intervention protocol.
- Provision of written informed consent.
You may not qualify if:
- Pregnancy or lactation. Current use of antibiotics, probiotic or prebiotic supplements during the study period or within the specified washout period (if applicable in your protocol).
- Presence of severe gastrointestinal, renal, hepatic, endocrine, or other serious chronic diseases that could affect study outcomes.
- Known allergy or intolerance to kefir or dairy products. Inability to comply with the intervention or follow-up procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pınar Göbellead
Study Sites (1)
Healthy Living Center, Karabük
Karabük, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- This was an open-label study because participants and investigators were aware of the assigned intervention. No masking was implemented.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assoc Prof Dr
Study Record Dates
First Submitted
September 18, 2026
First Posted
September 25, 2026
Study Start
June 1, 2024
Primary Completion
September 30, 2024
Study Completion
December 31, 2024
Last Updated
September 25, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share